Accelerating Development of Technology for CO₂-derived Aromatic Compounds
-Towards Future Independence from Fossil Resources-
September 25, 2025
Administration Office,
Utilization of Carbon Dioxide Institute Co., Ltd..
Utilization of Carbon Dioxide Institute Co., Ltd. (UCDI) is pleased to announce a newly developed technology for generating aromatic compounds such as phenol,
4-hydroxybenzoic acid (4-HBA), catechol, and protocatechuic acid from carbon dioxide (CO₂). A patent application has been filed for this new technology as the company explores modalities for its practical application.
Aromatic compounds are essential ingredients of widely used everyday products such as plastics, resins, pharmaceuticals, fragrances, and dyes. Most aromatic compounds are currently produced via petrochemical processes, thereby exposing them to all the downsides of adverse environmental impacts of CO₂ emissions, fluctuations in crude oil prices, and geopolitical risks. In recent years, a growing demand to establish sustainable production methods divorced from fossil resources has been driven by the pursuit of carbon neutrality.
- Technical Overview -
UCDI® Hydrogen Bacteria have a high inherent potential to produce organic compounds from CO₂ and hydrogen. By successfully implementing the company’s proprietary enzyme catalyst technology in the Bacteria, UCDI has pioneered a biosynthetic pathway for aromatic compounds, a pathway upon which new technology for producing aromatic compounds from CO₂ will be based. With the new technology, CO2 emissions can be significantly suppressed compared to those attendant to conventional fossil resources. Moreover, the new technology offers obvious advantages over production of aromatic compounds from biomass resources where securing raw materials and logistics costs are issues. The new technology utilizes a universal resource, CO₂, and thus affords stable and sustainableproduction.
Aromatic compounds produced by UCDI® Hydrogen Bacteria involve an innovative technology that can contribute to the sustainability of the entire chemical industry from the perspective of economic security. This new approach to both reducing environmental impact and ensuring a stable supply of resources avoids dependence on fossil or agricultural resources.
Since its establishment in 2015, UCDI has collaborated with the public as well as private sectors to advance research on and commercialization of CO2 as a resource. Centered on its proprietary UCDI® Hydrogen Bacteria, the company’s mission calls for “using innovative biotechnology to realize CO₂ as an energy resource that contributes towards addressing food shortages and global warming.
The company has made steady progress in research and commercialization of CO₂ resources with UCDI® Hydrogen Bacteria at the core. It continues to pursue technological innovations towards practical application of its nascent technology and strengthen efforts toward the realization of a carbon-recycling society.
Utilization of Carbon Dioxide Institute Co., Ltd.
<Company Profile>
Head Office/ Research Institute | 14F, Tradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo, Japan |
Representative | Dr. Hideaki Yukawa(CEO/CSO) |
Established | August 12, 2015 |
Paid-in Capital | ¥247 million |
HP |
<Business Fields>
UCDI pursues research, development, and commercialization of innovative biotechnologies based on the capacity of UCDI® Hydrogen Bacteria to utilize CO₂ as a nutrient. 1 cell can multiply to 16 million individuals in 24 hours (1 gram of cells grows 16 tonnes of cell mass in 24 hours).
Within the three business fields of Protein (for human consumption), Bioenergy and SAF, and Chemicals (various chemical products), the company aims to contribute solutions that address problems of food shortage and dependence on fossil resources.
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。
このプレスリリースを配信した企業・団体

- 名称 株式会社CO2資源化研究所
- 所在地 東京都
- 業種 その他製品
- URL https://www.co2.co.jp/jp/top/